These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 37220622)

  • 1. Blood Kallikrein-8 and Non-Amnestic Mild Cognitive Impairment: An Exploratory Study.
    Schramm S; Krizanovic N; Roggenbuck U; Jöckel KH; Herring A; Keyvani K; Jokisch M
    J Alzheimers Dis Rep; 2023; 7(1):327-337. PubMed ID: 37220622
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is kallikrein-8 a blood biomarker for detecting amnestic mild cognitive impairment? Results of the population-based Heinz Nixdorf Recall study.
    Schramm S; Jokisch M; Jöckel KH; Herring A; Keyvani K
    Alzheimers Res Ther; 2021 Dec; 13(1):202. PubMed ID: 34930454
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sex-Specific Differences in Serum Kallikrein-8 (KLK8): An Exploratory Study.
    Krizanovic N; Jokisch M; Jöckel KH; Schmidt B; Stang A; Schramm S
    J Alzheimers Dis; 2024; 100(2):495-507. PubMed ID: 38995781
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Depression and mild cognitive impairment in the general population: results of the Heinz Nixdorf recall study.
    Dlugaj M; Winkler A; Dragano N; Moebus S; Jöckel KH; Erbel R; Weimar C;
    J Alzheimers Dis; 2015; 45(1):159-74. PubMed ID: 25471191
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fluctuation of depressive symptoms in cognitively unimpaired participants and the risk of mild cognitive impairment 5 years later: Results of the Heinz Nixdorf Recall study.
    Jokisch M; Schramm S; Weimar C; Moebus S; Gronewold J; Dragano N; Jöckel KH
    Front Behav Neurosci; 2022; 16():988621. PubMed ID: 36386784
    [TBL] [Abstract][Full Text] [Related]  

  • 6. N-Terminal Pro-B Type Natriuretic Peptide is Associated with Mild Cognitive Impairment in the General Population.
    Kara K; Mahabadi AA; Weimar C; Winkler A; Neumann T; Kälsch H; Dragano N; Moebus S; Erbel R; Jöckel KH; Jokisch M
    J Alzheimers Dis; 2017; 55(1):359-369. PubMed ID: 27636851
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of Depressive Symptoms on Conversion from Mild Cognitive Impairment Subtypes to Alzheimer's Disease: A Community-Based Longitudinal Study.
    Kida J; Nemoto K; Ikejima C; Bun S; Kakuma T; Mizukami K; Asada T
    J Alzheimers Dis; 2016; 51(2):405-15. PubMed ID: 26890740
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association Between Olfactory Dysfunction and Amnestic Mild Cognitive Impairment and Alzheimer Disease Dementia.
    Roberts RO; Christianson TJ; Kremers WK; Mielke MM; Machulda MM; Vassilaki M; Alhurani RE; Geda YE; Knopman DS; Petersen RC
    JAMA Neurol; 2016 Jan; 73(1):93-101. PubMed ID: 26569387
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence and prognostic value of CSF markers of Alzheimer's disease pathology in patients with subjective cognitive impairment or mild cognitive impairment in the DESCRIPA study: a prospective cohort study.
    Visser PJ; Verhey F; Knol DL; Scheltens P; Wahlund LO; Freund-Levi Y; Tsolaki M; Minthon L; Wallin AK; Hampel H; Bürger K; Pirttila T; Soininen H; Rikkert MO; Verbeek MM; Spiru L; Blennow K
    Lancet Neurol; 2009 Jul; 8(7):619-27. PubMed ID: 19523877
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of diabetes mellitus and mild cognitive impairment in middle-aged men and women.
    Winkler A; Dlugaj M; Weimar C; Jöckel KH; Erbel R; Dragano N; Moebus S
    J Alzheimers Dis; 2014; 42(4):1269-77. PubMed ID: 25024326
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Subjective Spatial Navigation Complaints - A Frequent Symptom Reported by Patients with Subjective Cognitive Decline, Mild Cognitive Impairment and Alzheimer's Disease.
    Cerman J; Andel R; Laczo J; Vyhnalek M; Nedelska Z; Mokrisova I; Sheardova K; Hort J
    Curr Alzheimer Res; 2018; 15(3):219-228. PubMed ID: 29165083
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The validity of amnestic MCI and non-amnestic MCI at age 75 in the prediction of Alzheimer's dementia and vascular dementia.
    Jungwirth S; Zehetmayer S; Hinterberger M; Tragl KH; Fischer P
    Int Psychogeriatr; 2012 Jun; 24(6):959-66. PubMed ID: 22300486
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ankle-Brachial Index but Neither Intima Media Thickness Nor Coronary Artery Calcification is Associated With Mild Cognitive Impairment.
    Weimar C; Winkler A; Dlugaj M; Lehmann N; Hennig F; Bauer M; Kröger K; Kälsch H; Mahabadi AA; Dragano N; Moebus S; Hoffmann B; Jöckel KH; Erbel R;
    J Alzheimers Dis; 2015; 47(2):433-42. PubMed ID: 26401565
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Brain metabolism and cerebrospinal fluid biomarkers profile of non-amnestic mild cognitive impairment in comparison to amnestic mild cognitive impairment and normal older subjects.
    Coutinho AM; Porto FH; Duran FL; Prando S; Ono CR; Feitosa EA; Spíndola L; de Oliveira MO; do Vale PH; Gomes HR; Nitrini R; Brucki SM; Buchpiguel CA
    Alzheimers Res Ther; 2015 Sep; 7(1):58. PubMed ID: 26373380
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Olfactory identification in amnestic and non-amnestic mild cognitive impairment and its neuropsychological correlates.
    Vyhnalek M; Magerova H; Andel R; Nikolai T; Kadlecova A; Laczo J; Hort J
    J Neurol Sci; 2015 Feb; 349(1-2):179-84. PubMed ID: 25614440
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activities of Daily Living and Depressive Symptoms in Patients with Subjective Cognitive Decline, Mild Cognitive Impairment, and Alzheimer's Disease.
    Stogmann E; Moser D; Klug S; Gleiss A; Auff E; Dal-Bianco P; Pusswald G; Lehrner J
    J Alzheimers Dis; 2016; 49(4):1043-50. PubMed ID: 26577522
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Altered Frequency-Dependent Brain Activation and White Matter Integrity Associated With Cognition in Characterizing Preclinical Alzheimer's Disease Stages.
    Wang S; Rao J; Yue Y; Xue C; Hu G; Qi W; Ma W; Ge H; Zhang F; Zhang X; Chen J
    Front Hum Neurosci; 2021; 15():625232. PubMed ID: 33664660
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Language Differences Among Individuals with Normal Cognition, Amnestic and Non-Amnestic MCI, and Alzheimer's Disease.
    Liampas I; Folia V; Morfakidou R; Siokas V; Yannakoulia M; Sakka P; Scarmeas N; Hadjigeorgiou G; Dardiotis E; Kosmidis MH
    Arch Clin Neuropsychol; 2023 May; 38(4):525-536. PubMed ID: 36244060
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biomarkers in subtypes of mild cognitive impairment and subjective cognitive decline.
    Eliassen CF; Reinvang I; Selnes P; Grambaite R; Fladby T; Hessen E
    Brain Behav; 2017 Sep; 7(9):e00776. PubMed ID: 28948074
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of diabetes with amnestic and nonamnestic mild cognitive impairment.
    Roberts RO; Knopman DS; Geda YE; Cha RH; Pankratz VS; Baertlein L; Boeve BF; Tangalos EG; Ivnik RJ; Mielke MM; Petersen RC
    Alzheimers Dement; 2014 Jan; 10(1):18-26. PubMed ID: 23562428
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.